The company says the observations are procedural in nature.
Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA
Published 1 hour ago
Source: thehindu.com
Categories
Industry
Related Articles from thehindu.com
15 minutes ago
Cash-for-query: Delhi HC quashes Lokpal order against Mahua Moitra
16 minutes ago
Australia's 'Bondi Hero' handed millions collected from fundraising
20 minutes ago
Health sector in T.N. to see consolidation of multi-speciality entities, says expert
21 minutes ago
Bombay HC restrains sale of ‘CEFDON’ cough syrup, cites deceptive similarity with ‘CEDON’
28 minutes ago
‘Made in Maharashtra’ liquor policy: Bombay High Court seeks State’s reply
36 minutes ago